Vanda Pharmaceuticals buy StockNews.com
Start price
04.03.23
/
50%
€5.90
Target price
04.03.24
-
Performance (%)
-34.24%
End price
05.03.24
€3.88
Summary
This prediction ended on 05.03.24 with a price of €3.88. The BUY prediction by StockNews_com for Vanda Pharmaceuticals performed very badly with a performance of -34.24%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | 0.862% | 0.862% | 29.425% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten